Drug Profile
4-IBB ligand gene therapy
Latest Information Update: 24 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer
Most Recent Events
- 28 Jul 2000 Preclinical development for Colorectal cancer in USA (Unknown route)